1. EPWORTH Knowedge Bank
  2. Academic & Clinical
  3. Cancer Services
Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/440
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMurphy, Declan-
dc.contributor.otherChow, Ken-
dc.date2014-
dc.date.accessioned2015-10-20T04:50:15Z-
dc.date.available2015-10-20T04:50:15Z-
dc.date.issued2014-10-
dc.identifier.citationEuropean Urology 2014 Oct;66(4):785-6en_US
dc.identifier.issn0302-2838en_US
dc.identifier.issn1421-993Xen_US
dc.identifier.urihttp://hdl.handle.net/11434/440-
dc.description.abstractComment on Enzalutamide in metastatic prostate cancer before chemotherapy. [N Engl J Med. 2014]en_US
dc.publisherElsevieren_US
dc.subjectEpworth Prostate Centre, Epworth Healthcare, Richmond, Victoria, Australiaen_US
dc.subjectProstate Canceren_US
dc.subjectProstate Neoplasmsen_US
dc.subjectNeoplasms, Prostateen_US
dc.subjectCancer of the Prostateen_US
dc.subjectEnzalutamideen_US
dc.subjectAntineoplastic Agentsen_US
dc.subjectCancer Chemotherapy Drugsen_US
dc.subjectChemotherapeutic Anticancer Agentsen_US
dc.subjectAnticancer Agentsen_US
dc.subjectChemotherapyen_US
dc.subjectTherapy, Drugen_US
dc.subjectPharmacotherapyen_US
dc.subjectDrug Therapyen_US
dc.titleWord of wisdom. Re: enzalutamide in metastatic prostate cancer before chemotherapy.en_US
dc.typeCommentsen_US
dc.identifier.doidx.doi.org/10.1016/j.eururo.2014.07.049en_US
dc.identifier.journaltitleEuropean Urologyen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/25218073-
dc.description.affiliatesDepartment of Urology, Royal Melbourne Hospital, Melbourne, Victoria, Australiaen_US
dc.description.affiliatesDivision of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australiaen_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services
Epworth Prostate Centre
UroRenal, Vascular

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.